The China Health Care Association of the Peptide and Health Industry Branch was held in Beijing

To actively promote the implementation of the “Healthy China” strategy, promote China’s development peptide health industryand fully show the important role of the peptide industry in health.

On June 26, 2022, the “China Health Care Association Peptide and Health Industry Branch Inaugural Meeting and Co-creation of Vitality Peptide Industry Development Seminar” hosted by China Health Care Association and conducted by Taiai Peptide Group was successfully held in held in Beijing. Huang Jiansheng, vice chairman of the China Health Care Association, Xu Huafeng, vice chairman and secretary-general of the China Health Care Association, Li Ping, vice chairman of the China Health Care Association, Wu Xia, chairman of Taiai peptide group, Ren Yan, Dual Doctorate in Traditional Chinese Medicine and Clinical Nutrition, Ding Gangqiang, Director of the Nutrition and Health Institute of the Chinese Center for Disease Control and Prevention, Qiao Wei, President of Sales and Marketing Operations of Taiai Peptide Group, Chen Ye , Chief Executive Taiai Peptide Group Officer Wang Fabing, Chairman of Shandong Peptide Dingwu Technology Co., Ltd., Chongqing Jiaer Biotechnology Co., Ltd. Li Changjun, General Manager of Institute of Technology, Zhao Qingguo, General Manager of Henan Yikang Youpin Health Management Co., Ltd. and nearly 100 people, including representatives from online participating companies and business leaders, attended the meeting. The meeting was hosted by Li Ping, vice chairman of the China Health Care Association. mrs hosted.

Li Ping, vice chairman of the China Health Care Association, chaired the meeting.

At the inauguration ceremony, Vice Chairman Li Ping stressed in the background of the establishment of the Peptide and Health Industry Branch of the China Health Care Association: The China Health Care Association is an industry association established in 2003 by the Ministry of Health and the Ministry of Civil Affairs and submitted to the State Council for approval . Serve Business, Serve Consumer”. She also pointed out that the establishment of the China Health Care Association’s peptide and health industry department meets and meets people’s needs for comprehensive health.

Huang Jiansheng, executive vice chairman of the China Health Care Association, read the announcement of the establishment of the branch.

In the election of the industry leader, Vice Chairman Li Ping read out the candidate list for the head of Peptide and Health Industry Branch on site and made the final election decision of the conference: It was unanimously agreed that Wu Xia, Chairman of Taiai Peptide, acted as Branch President and Sinopharm Peptide Valley Co., Ltd. Shi Feng, president of the company, served as branch general secretary, Liu Xia, chairman of Shandong Hualong Group, served as branch vice president, and Zhao Xuhui of Taiai Peptide served as executive deputy general secretary.

Huang Jiansheng, Vice Chairman of the Board, issued the industry certificate and awarded the Board of Directors to Tai Ai Peptide Director Unit and Member Unit. Huang Jiansheng, Vice Chairman of the Board, presented the Board of Directors of Tai Ai Peptide Council.

Wu Xia, President-elect of the Peptide and Health Industry Branch of the China Health Care Association, delivered an inaugural speech.

Wu Xia, Chairman of Taiai Peptide, delivered a speech at the inauguration of the President of the Peptide and Healthcare Industry.

In his inaugural address, President Wu said: As the president of the branch, I am committed to the development of the branch. In the future, under the guidance and support of the AGM, the branch will thoroughly implement the “Healthy China” strategy to “help the government to help businesses with the aim of “serving consumers” and will carry out activities in related fields to peptides and the major health industry and build the “Peptide and Health Industry Branch” into a professional, standardized and standardized industry body and provide R&D support to the health industry and its member units. technical support, sales support and other comprehensive services and support, play the role of a bridge and link between members and the government. Promote the development of China’s health industry and help a healthy China!Professor Ding Gangqiang, director of the Institute of Nutrition and Health of the China Center for Disease Control and Prevention, shared this online.

Professor Ding Gangqiang first explained the importance of peptides to human health from different perspectives. He said: In China, the pressure of an aging society is relatively high. Older people over 60 years old make up 18.3% of the total population, and older people over 65 years old make up 13.5%. With age, the physiological functions of the elderly decline, amino acids, peptides and proteins can strengthen their immune function; The current country pays special attention to people’s health, especially in the current epidemic, so that each of us can have a healthy life. The establishment of the peptide and health industry department under the China Health Care Association is of great significance. It is of great importance to unite our good companies to discuss the biological mechanism of the development of related peptides and the promotion of macro politics.

Online sharing from Dr. Yandong Ren, a dual doctorate in traditional Chinese medicine and clinical nutrition.

dr Ren Yandong said in his speech that the establishment of the Peptide and Health Industry Branch is a weathervane for the industry. President Wu Xia has always been committed to promoting the development of the peptide industry and raising the industry to a higher level. In today’s clinical nutrition research, peptides are used as basic raw materials of proteins, and multifunctional peptides have become the focus of global nutrition. The products researched by Taiai Peptide feature both high-level technical structural design and technological breakthroughs, which have propelled the development of nutritional health industry. Last year I also did in-depth research with President Wu Xia on peptide supplements for osteoarthritis. Through clinical experiments, we have seen encouraging results of peptide supplements in preventing and treating chronic diseases. From the perspective of chronic diseases, the development of peptide dietary supplements and industry can actually advance chronic disease prevention and treatment technologies and services in China. Xu Huafeng, vice chairman and general secretary, mentioned in his speech: President Wu Xia and the industry chain companies communicated with the association and the official establishment of the industry today. a process. It is hoped that within the purpose of the health association, the peptide and health industry branch can better promote the improvement of health policy, promote the standardized development of the health industry, promote the implementation of the “Healthy China” strategy, and promote people’s health literacy. Improvement.

The establishment of the Peptide and Health Industry Branch marks the establishment of a new social integration mechanism and communication platform in the peptide and health field in China.)” to promote the cause of national health and build a platform for industry exchanges. It has important practical significance and far-reaching historical significance in accelerating the standardization and standardization process of the folk country’s peptide industry, promoting the healthy development of the peptide industry, and accelerating the transformation of the scientific research results of the peptide industry into the great health industry.

Taiai peptide group has been focusing on the field of small molecule peptides for 25 years, and has developed into a group company integrating R&D, production, sales and service, and has a number of core technology patents. The group has always adhered to the research and development spirit of “endless life, endless scientific research”, and has always set as the corporate goal of “let the common people drink peptides and have a good body”. It has more than 300 scientific research achievements, more than 50 independent products, 10. 10,000-level GMP workshop standard, has a production capacity of more than 5,000 tons. After the Taiai peptide production base in Heze, Shandong is put into operation in 2022, it will reach a daily production capacity of 150,000 boxes. After continuous innovation and development, the market includes diversified business areas such as specialty dishes, cosmetics and international trade. Providing total solution such as original powder, ODM, OEM, brand agency, etc. to the world.

Taiai Peptide Group will make full use of its position and advantages in China peptide industryIntegrate resources, focus on industrial scientific research and capital, achievements and markets, provide a full range of services and support for the health industry and its member units, and support the development of the peptide and health industry industry to make positive contributions positive development of China’s bioactive peptide industry and to support people’s health!

media contact
Name of the company: Shandong Taiai Peptide Biotechnology Co., Ltd.
E-mail: Send e-mail
Phone: 0086-19933321205
Address:The right side of Guihua 1st Road, Heze Modern Medicine Port, Changjiang East Road, Development Zone
City: heze
Federal State: shandong
Country: China
Website: https://www.taiaitaibiology.com/

Comments are closed.